Visualizing Health Policy: Recent Trends in Prescription Drug Costs
This Visualizing Health Policy infographic with JAMA spotlights national spending on prescription drugs and the public’s views on pharmaceutical prices.
View the Latest: Prices
Filter
-
-
How Do Health Care Prices and Utilization in the United States Compare to Peer Nations?
Issue BriefThis updated chart collection compares indicators of health care utilization and prices in the United States and 11 similarly wealthy countries to investigate whether higher prices or higher utilization of health care services drives the high health care expenditures in the U.S. relative to peer nations.
-
The Only Health Care Prices That Matter to Consumers
From Drew AltmanIn this column, Drew Altman zeroes in on a key test for when the implementing rules are written for the new executive order on hospital price transparency: consumers will need to know what amount they must pay out of pocket to really help them shop on price.
-
Prescription Drugs’ Sizable Share of Health Spending
From Drew AltmanIn this column for The Wall Street Journal’s Think Tank, Drew Altman explains why prescription drug spending may be a larger share of health spending than most people think, depending on how you look at it.
-
Prescription Drugs’ Sizable Share of Health Spending
News ReleaseIn his latest column for The Wall Street Journal‘s Think Tank, Drew Altman explains why prescription drug spending may be a larger share of health spending than most people think, depending on how you look at it. All previous columns by Drew Altman are online.
-
How High Drug Prices Weigh on the Sickest Americans
From Drew AltmanIn this column for The Wall Street Journal's Think Tank, Drew Altman explores the data behind public concern about prescription drug costs and highlights that the people most in need are the most burdened by the problem.
-
Web Event: Rx Drugs and the U.S. Health System – A Conversation about Election-Cycle Proposals for Lowering Costs
Event Date:EventOn Wednesday, October 5, from noon to 1 p.m. ET, the Kaiser Family Foundation will host a web conversation to discuss proposals for controlling prescription drug costs, examine pros and cons of the ideas, and assess the likelihood that the plans will be enacted.
-
Price Regulation, Global Budgets, and Spending Targets: A Road Map to Reduce Health Care Spending, and Improve Affordability
ReportWe review several policy options to constrain health care spending, primarily by putting downward pressure on provider prices, including price regulation, global budgets, and spending growth targets.
-
Assessing Online Availability of At-Home COVID-19 Tests Ahead of Private Insurance Reimbursement
Issue BriefThis data note explores findings from on an 8-day online search for at home COVID-19 tests at major retailers. The findings are described against the backdrop of the Biden Administration policy requiring plans to cover the cost of these tests. We find that these tests remain hard to find and that this limited availability could negatively affect the success of the reimbursement strategy.
-
Few Consumers Use Information on Health Provider Quality or Price
From Drew AltmanIn this column for The Wall Street Journal's Think Tank, Drew Altman discusses new poll findings showing very small numbers of consumers are using provider quality and price information.